Literature DB >> 30365874

TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation.

C Lemattre1, J Thevenon2,3, Y Duffourd2,4,5,6, S Nambot2, E Haquet1, B Vuadelle7, D Genevieve1, P Sarda1, A L Bruel2, P Kuentz2,8, C F Wells1, L Faivre2,6, M Willems1.   

Abstract

Pierpont syndrome is a rare and sporadic syndrome, including developmental delay, facial characteristics, and abnormal extremities. Recently, a recurrent de novo TBL1XR1 variant (c.1337A > G; p.Tyr446Cys) has been identified in eight patients by whole-exome sequencing. A dominant-negative effect of this mutation is strongly suspected, since patients with TBL1XR1 deletion and other variants predicting loss of function do not share the same phenotype. We report two patients with typical Pierpont-like syndrome features. Exome sequencing allowed identifying a de novo heterozygous missense TBL1XR1 variant in both patients, different from those already reported: p.Cys325Tyr and p.Tyr446His. The localization of these mutations and clinical features of Pierpont-like syndrome suggest that their functional consequences are comparable with the recurrent mutation previously described, and provided additional data to understand molecular mechanisms of TBL1XR1 anomalies.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Pierpont syndrome; TBL1XR1

Mesh:

Substances:

Year:  2018        PMID: 30365874     DOI: 10.1002/ajmg.a.40510

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  Nuclear Receptor Coactivators (NCOAs) and Corepressors (NCORs) in the Brain.

Authors:  Zheng Sun; Yong Xu
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

Review 2.  Nuclear receptor corepressors in intellectual disability and autism.

Authors:  Yan Kong; Wenjun Zhou; Zheng Sun
Journal:  Mol Psychiatry       Date:  2020-02-07       Impact factor: 15.992

3.  Pierpont syndrome-Report of a new patient.

Authors:  Vlora Ismaili-Jaha; Shqipe Spahiu-Konusha; Art Jaha
Journal:  Clin Case Rep       Date:  2021-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.